IERARDI, ENZO GIANNI
 Distribuzione geografica
Continente #
NA - Nord America 5.329
EU - Europa 4.246
AS - Asia 3.052
SA - Sud America 319
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 8
Totale 12.993
Nazione #
US - Stati Uniti d'America 5.289
CN - Cina 1.446
IE - Irlanda 1.302
UA - Ucraina 1.036
SG - Singapore 814
SE - Svezia 726
RU - Federazione Russa 357
HK - Hong Kong 289
BR - Brasile 276
IT - Italia 246
TR - Turchia 218
FI - Finlandia 180
IN - India 175
FR - Francia 137
GB - Regno Unito 135
DE - Germania 63
VN - Vietnam 52
CA - Canada 22
AR - Argentina 20
EU - Europa 13
MX - Messico 11
PL - Polonia 11
ZA - Sudafrica 11
ES - Italia 9
NL - Olanda 8
EC - Ecuador 7
IQ - Iraq 7
PK - Pakistan 6
BD - Bangladesh 5
BE - Belgio 5
CZ - Repubblica Ceca 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
AT - Austria 4
AU - Australia 4
EG - Egitto 4
JP - Giappone 4
NZ - Nuova Zelanda 4
TN - Tunisia 4
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
LT - Lituania 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CO - Colombia 2
GE - Georgia 2
ID - Indonesia 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
LV - Lettonia 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
RO - Romania 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
SV - El Salvador 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 12.993
Città #
Dublin 1.300
Chandler 917
Jacksonville 734
Dearborn 580
Nanjing 376
Nyköping 374
Singapore 337
Ashburn 300
Hong Kong 288
Wilmington 218
Beijing 183
Santa Clara 155
Princeton 146
San Mateo 144
Nanchang 115
Boardman 114
Woodbridge 85
Kunming 73
Hebei 69
Shenyang 69
Ann Arbor 63
Dallas 62
Moscow 62
Tianjin 59
Des Moines 58
Jiaxing 54
Changsha 50
Guangzhou 43
Los Angeles 40
Shanghai 35
Hilden 34
Helsinki 33
The Dalles 32
Hangzhou 31
Jinan 30
New York 29
Seattle 29
Stevenage 28
São Paulo 23
Pune 18
Changchun 17
Council Bluffs 16
Ho Chi Minh City 15
Ningbo 15
Rio de Janeiro 14
Taizhou 14
Brooklyn 13
Rome 13
Dong Ket 12
Norwalk 12
Shenzhen 12
Auburn Hills 11
Boston 11
Philadelphia 11
Zhengzhou 11
Lanzhou 10
Hanoi 9
Warsaw 9
London 8
Wuhan 8
Wuxi 8
Belo Horizonte 7
Hefei 7
Phoenix 7
Quanzhou 7
Milan 6
Bari 5
Brasília 5
Brussels 5
Chennai 5
Florence 5
Fuzhou 5
Hanover 5
Johannesburg 5
Montreal 5
Napoli 5
Saint Petersburg 5
Amsterdam 4
Borås 4
Contagem 4
Fairfield 4
Hillsboro 4
Jeddah 4
Mumbai 4
Orange 4
Quito 4
San Francisco 4
Sydney 4
Tokyo 4
Washington 4
Asti 3
Atlanta 3
Auckland 3
Baghdad 3
Baku 3
Bologna 3
Casoria 3
Cedar Knolls 3
Chicago 3
Dhaka 3
Totale 7.810
Nome #
LA COLITE SEGMENTARIA ASSOCIATA AI DIVERTICOLI: USO DEL DEL bECLOMETASONE dipropionatoNELLE FORME EMORRAGICHE 308
Helicobacter Heilmannii: un nuovo batterio dello stomaco. Come si ricerca e suo ruolo nella pratica clinica 150
"Clarithromycin-resistant genotypes and eradication of Helicobacter pylori." 127
Onset of liver damage after a single administration of infliximab in a patient with refractory ulcerative colitis. 127
Argon plasma coagulation in the treatment of haemorragic solitary ulcer syndrome. 122
57. M Barone, E Maiorano, R Ladisa, A Pece, P Berloco, M Strazzabosco, ML Caruso, AM Valentini, E Ierardi, A Di Leo, A Francavilla. Ursodeoxycholate further increases bile duct cell proliferative response induced by partial bile duct ligation in rats. 119
A case of adverse reaction potentially related to a microbubble contrast agent for ultrasonography. 119
Argon plasma coagulation of haemorragic solitary rectal ulcer syndrome. 118
Acid exposure and altered acid clearance in GERD patients treated for Helicobacter pylori infection. 115
H. pylori antibiotic resistance and 13C urea breath test values. J Med Microbiol. 2010 Jan 21. 112
Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab. 110
"Nutrizione in Gastroenterologia" 110
Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost-effectiveness 110
Circadian rhythm of hepatic estrogen receptors 110
Helicobacter pylori and chronic antral erosions: our experience. 109
An inter and intra-laboratory comparison of breath 13CO2 . 109
Pseudotumoural lesion of the abdominal wall due to a fishbone migration 109
Modulation of rat Hepatocyte proliferation by bile salts: in vitro and in vivo studies 109
Peritoneo-venous shunting for ascites: a five year experience with LeVeen and Denver shunts. 108
The augmenter of liver regeneration induces mithochondrial gene expression in rat liver and enhances oxidative phosphorylation capacity of liver mithochondria. 107
Binding of Campylobacter pylori to human peripheral blood lymphocytes 107
H. pylori vacA arrangement and related diseases: a retrospective study over a period of 15 years 107
Autoantibodies reacting with gastric antigens in Helicobacter pylori gastritis of dyspeptic children 105
Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV seronegative pregnant women: a 24 month prospective study. 104
A life threatning event following the injection of a microbubble contrast agent for ultrasonography. 104
"Alterazioni dello stato nutrizionale" 104
Endoscopic ultrasound localization of a solitary insulinoma of pancreatic tail misdiagnosed as epilepsy: case report 104
Liver damage onset after a single infliximab administration in a patient with refractory ulcerative colitis 103
Circadian rhythm of hepatic estrogen receptors. 103
I breath tests nell’ insufficienza panctreatica, nelle malattie epatiche e nell’ alitosi. 103
I nucleotidi ciclici (cAMP e cGMP) nell' ascite come markers di recidiva da carcinoma ovarico. 101
Malattia da reflusso gastro-esofageo e dispepsia non ulcerosa. 100
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses. 99
Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicenter study. 99
A new semiquantitative method of quantifying Helicobacter pylori antigen in stools 99
Epidemiology of gastroesophageal reflux 99
Cyclic nucleotides in ascites from ovarian carcinoma 99
Malnutrizione in Gastroenterologia. 98
Incidence and risk factors of duodenal ulcer 97
A serologic survey of Helicobacter pylori infection in 3281 Italian patients endoscoped for upper gastrintestinal symptoms 96
Minimal inhibitory concentration (MIC) values and different point mutations in the 23S rRNA gene for clarithromycin resistance in Helicobacter pylori 96
A oral Tacrolimus long-term therapy in parients with Crohn’s disease and steroid resistance 95
A third-line levofoxacin-based rescue therapy for Helicobacter pylori eradication. 94
Anisakis pegreffi etiological agent of gastric infections in two Italian women. 94
Gastric epithelial cell proliferation and ras oncogene p21 expression in first-degree relatives of gastric cancer patients: a case-control study. 94
Campylobacter fetus bacteriemia in an immunocompromised patient: a case report and review of literature. 94
The pattern of mucosal tumor necrosis factor-α expression in segmental colitis associated to diverticula suggests a truly autonomous clinical entity. 94
Immunohistostaining of hepatitis C virus (HCV) non-structural protein 4 (NS 4) in ependymocytes of uninfected mice: an antigenic mimicry? 93
Update on Helicobacter pylori research. Malignancies. 92
Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia. 92
Sequential therapy for H. pylori: an “aberrant” therapy ready for general use. 92
Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits 92
Altered molecular pattern of mucosal healing in Crohn's disease fibrotic stenosis. 92
Proliferative Activity of Gastric Epithelium in Progressive Stages of Helicobacter pylori Infection. 91
Immunohistochemical detection of Helicobacter Pylori vacuolating cytoxin in the hepatocytes of patients with isolated hypertransaminasemia 91
Effect of Helicobacter pylori eradication on intestinal metaplasia and gastric epithelium proliferation 91
There is a role for sequential in sequential anti-H. pylori therapy? (Reply of the authors). 90
Role of different clarithromycin resistance genotypes on Helicobacter pylori eradication. 90
Effect of Lactobacillus reuteri on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy in children: a randomised clinical trial 90
Does tauroursodeoxycholic acid (TUDCA) treatment increase hepatocyte proliferation in patients with chronic liver disease? 90
Gastrospirillum hominis and human chronic gastritis 89
Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice 88
Guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. 88
Treatment of a pancreatic endocrine tumor by ethanol injection guided by endoscopic ultrasound. 88
Claritromycin resistance and Helicobacter pylori genotypes in Italy. 88
Ruolo attuale e progressi tecnologici dell’ecografia transaddominale nell’ imaging delle vie biliari 88
Helicobacter species in liver and biliary diseases. 87
Endoultrasonographic guided alcohol lavage of a pancreatic fluid collection: a case report 87
Tumour necrosis factor alpha and apoptosis in Helicobacter pylori related progressive gastric damage: a possible mechanism of immune system involvement in epithelial turnover regulation 87
The prolongation of triple therapy for Helicobacter pylori does not allows reaching therapeutic outcome of sequential scheme: a prospective, randomized study. 87
Tumor necrosis alpha serum levels parallels isolated hypertransaminasemia in the third trimester of pregnancy 87
Celiac plexus under endoscopy ultrasonographic guidance complication. 86
ER-beta expression in large bowel adenomas: Implications in colon carcinogenesis. 86
Small intestinal contrast ultrasonograpy based scoring system: a promising approach for the diagnosis and follow-up of celiac disease. 86
Tumor necrosis factor alpha in ulcerative colitis and diverticular disease associated colitis. 86
Gastro-esophageal reflux disease and lactose malabsorption: casual comorbidity or neglected association? 86
Estrogens, androgens and EGF receptor expression in gastric carcinoma induced by N-methyl-N'-nitro-N-nitrosoguanidine. 85
Reflux symptoms in professional opera choristers. 85
DNA sequences and proteic antigens of H. pylori in cholecystic bile and tissue of patients with gallstones. 85
Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study. 85
Lupus nephritis improvement after anti-tumour necrosis factor alpha monoclonal antibody (Infliximab) treatment for Crohn’s disease: a case report. 85
Effect of eradicating therapy on cell proliferation in Helicobacter pylori-related lesions 85
Evaluation of a commercial serological kit for detection of salivary immunoglobulin G to Helicobacter pylori: a multicenter study. 84
Epithelial proliferation and ras p21 oncoprotein expression in rectal mucosa of patients with ulcerative colitis 84
Pattern of apoptosis in Crohn’ s disease: a singular aspect. 84
Symptoms and pathophysiological correlations in patients with constipation and functional dyspepsia. 84
“Mycophenolate mofetil in the treatment of autoimmune hcv-associated haematological disorders showing steroid resistance or dependence.” J Viral Hepat 84
Two new treatment regimens for Helicobacter pilori eradication: a randomised study 84
Worldwide H. pylori antibiotic resistance: a systematic review. 84
“Probiotic Multistrain Treatment May Eradicate Helicobacter pylori from the Stomach of Dyspeptics: A Placebo-Controlled Pilot Study.” Inflamm Allergy Drug Targets. 2012 Jun 1;11(3):244-9 84
Helicobacter Heilmannii gastritis: a histological and immunohistochemical trait 83
Improved Efficacy of 10 Day Sequential Treatment For Helicobacter Pylori Eradication In Children: A Randomised Trial. 83
Effects of ranitidine: a short-term clinical trial for duodenal ulcer treatment using two different types of oral administration. Serum prolactin stimulation after bolus injection. 83
The use of human albumin for the treatment of ascites in patients with liver cirrhosis: item of safety, facts, controversies and perspectives. 83
High eradication rates for Helicobacter pylori with a new sequential treatment. 82
Demonstration of a direct stimulatory effect of bile salts on rat colonic epithelial cell proliferation. 82
TUMOUR NECROSIS FACTOR ALPHA DOWNREGULATION AND BASIC FIBROBLAST GROWTH FACTOR/SYNDECAN 1 LINK: A POSSIBLE MOLECULAR PATHWAY OF MUCOSAL HEALING IN ULCERATIVE COLITIS 82
Pathways and gene expression profiles in hepatocellular carcinoma 82
Tumor necrosis factor alpha in segmental colitis associated with diverticula. 81
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. 80
Totale 9.783
Categoria #
all - tutte 65.968
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.968


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021658 0 0 0 0 0 154 165 10 153 157 5 14
2021/2022729 147 0 1 10 62 30 35 66 94 69 41 174
2022/20233.441 250 125 114 272 279 387 23 240 1.550 22 84 95
2023/2024454 111 26 22 15 57 149 1 28 0 5 0 40
2024/20251.811 94 39 98 90 94 310 146 142 483 55 131 129
2025/20261.111 184 123 271 396 106 31 0 0 0 0 0 0
Totale 13.043